Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma

POAG Clinical Trial

Official title:
A Prospective, Multicenter, First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the DF12 CANALOPLASTY AND TRABECULOTOMY SURGICAL SYSTEM in Subjects With Open-Angle Glaucoma Undergoing Cataract Surgery

Status Not yet recruiting

Clinical Trial Summary

Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects with Open-Angle Glaucoma

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05696561
Study type	Interventional
Source	New World Medical, Inc.
Contact	Heather P Reynolds, MS
Phone	8176881689
Email	hreynolds@newworldmedical.com
Status	Not yet recruiting
Phase	N/A
Start date	March 2024
Completion date	July 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02792803` - A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma	Phase 4
Recruiting	`NCT05062668` - Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma
Active, not recruiting	`NCT05278299` - Asia Glaucoma Registry
Recruiting	`NCT02312362` - High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP	N/A
Not yet recruiting	`NCT05902871` - Direct Selective Laser Trabeculoplasty in a Ethnic Chinese Population	N/A